Statins exert antitumor effects by inhibiting the mevalonate pathway, thereby disrupting key oncogenic signaling cascades such as the phosphoinositide 3-kinase/AKT and RAS/mitogen-activated protein kinase pathways, ultimately suppressing tumor proliferation and metastasis [13,17,18,19,32]. This evidence concerns the gene WNK2 and neoplasm.